Skip to main content
Clinical Trials/TCTR20201106003
TCTR20201106003
Recruiting
未知

Immature platelet fraction values predict platelet recovery following consolidation chemotherapy in AML patient

Siriraj Hospital Mahidol University0 sites41 target enrollmentNovember 6, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
The patients older than 18 years with acute myeloid leukemia after receiving chemotherapy.
Sponsor
Siriraj Hospital Mahidol University
Enrollment
41
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2020
End Date
October 29, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Siriraj Hospital Mahidol University

Eligibility Criteria

Inclusion Criteria

  • The patients older than 18 years with acute myeloid leukemia after receiving periodic chemotherapy consolidation with HiDAC or IDAC formulations

Exclusion Criteria

  • The patients with disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), immune thrombocytopenia (ITP), or systemic lupus erythematosus (SLE) with exacerbation.
  • Patients with hypersplenism.
  • Diagnosed with abnormal bone marrow platelet production, including aplastic anemia (AA), myelodysplastic syndrome (MDS).

Outcomes

Primary Outcomes

Not specified

Similar Trials